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Key summary points
Aim To guide LTCFs in preventing the entrance and spread of SARS-CoV-2.
Findings The guidance is based upon the literature available on August 17, 2020. It lists (1) measures that can be imple-
mented to keep COVID-19 out of LTCFs, and (2) COVID-19 symptoms that require RT-PCR testing in residents, staff 
members and visitors. It also (3) indicates the strategy to be used when a first LCTF resident or staff member is infected, and 
(4) proposes measures to limit adverse effects of the quarantine of residents tested positive for COVID-19.
Message The EuGMS guidance enables LTCFs to adapt and suitably implement infection prevention and control measures, 
considering that the priorities are (1) early detection of symptomatic and asymptomatic COVID-19 residents, staff members 
and visitors who contribute to the entrance and dissemination of COVID-19 infection in LTCFs and (2) to limit the negative 
effects of isolation in infected residents.
Abstract
Purpose The European Geriatric Medicine Society (EuGMS) is launching a second interim guidance whose aim is to prevent 
the entrance and spread of COVID-19 into long-term care facilities (LTCFs).
Methods The EuGMS gathered experts to propose a guide of measures to prevent COVID-19 outbreaks in LTCFs. It is based 
on the specific features of SARS-CoV-2 transmission in LTCFs, residents’ needs, and on experiences conducted in the field.
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Results Asymptomatic COVID-19 residents and staff members contribute substantially to the dissemination of COVID-
19 infection in LTCFs. An infection prevention and control focal point should be set up in every LTCF for (1) supervising 
infection prevention and control measures aimed at keeping COVID-19 out of LTCFs, (2) RT-PCR testing of residents, 
staff members, and visitors with COVID-19 symptoms, even atypical, and (3) isolating subjects either infected or in contact 
with infected subjects. When a first LCTF resident or staff member is infected, a facility-wide RT-PCR test–retest strategy 
should be implemented for detecting all SARS-CoV-2 carriers. Testing should continue until no new COVID-19 cases are 
identified. The isolation of residents should be limited as much as possible and associated with measures aiming at limiting 
its negative effects on their mental and somatic health status.
Conclusions An early recognition of symptoms compatible with COVID-19 may help to diagnose COVID-19 residents and 
staff more promptly. Subsequently, an earlier testing for SARS-CoV-2 symptomatic and asymptomatic LTCF staff and resi-
dents will enable the implementation of appropriate infection prevention and control. The negative effects of social isolation 
in residents should be limited as much as possible.
Keywords COVID-19 · SARS-CoV-2 · Guidance · Long-term care facility · rRT-PCR · Social isolation
Introduction
Long-term care facilities (LTCFs) across Europe encompass 
a broad range of institution types from home-like facilities 
to those providing specialised medical care. These facilities 
include nursing homes, skilled nursing facilities, retirement 
homes, assisted-living facilities, residential care homes, and 
palliative care or rehabilitation centres. All these services 
take care of older people who are no longer able to live 
independently in the community due to a combination of 
physical, mental, intellectual or sensory impairments. The 
European Centre for Disease Prevention and Control esti-
mates that in 2016–2017, there were 64,471 nursing homes, 
rehabilitation centres and mixed LTCFs in EU/EEA coun-
tries, representing a total of 3,440,071 beds [1].
As with the common cold, influenza and other com-
monly circulating human coronaviruses, LTCFs are high risk 
environments when it comes to severe outbreaks of SARS-
CoV-2 or coronavirus disease (COVID-19). Not only are 
LTCFs enclosed environments in which the virus can spread 
rapidly but, more importantly, LTCF residents are extremely 
vulnerable to complications from the virus, with a mortality 
rate of > 25% [2, 3].
Coronavirus outbreaks in LTCFs will probably continue 
to occur in Europe with the likelihood of tens of thousands 
of additional deaths if:
– Traditional infection-control and public health strategies 
are not adapted and implemented suitably for the specific 
features of COVID-19 transmission in LTCFs;
– The diagnostic strategy in residents and staff members is 
not adapted to the strengths and limitations of the SARS-
CoV-2 reverse transcription polymerase chain reaction 
(RT-PCR) testing;
– No measures are implemented to reduce the mental and 
physical adverse effects of quarantine in residents when 
it is necessary.
Taking into account the fact that countries have devel-
oped different approaches to prevent COVID-19 epidemics 
in LTCFs (https ://www.jnurs ingho meres earch .com/curre nt-
issue .html), the specific features of COVID-19 transmission 
in LTCFs (“Specific features of COVID-19 transmission in 
LTCFs”), properties of the SARS-CoV-2 testing (“Properties 
of the SARS-CoV-2 reverse transcription polymerase chain 
reaction (RT-PCR) testing when implemented in residents 
and staff members”), and adverse effects of social isolation 
and quarantine in residents (“Adverse effects of social isola-
tion and quarantine in residents”), the EuGMS is launching 
a second interim [4] guidance with a checklist aiming at the 
following: Preventing the entrance of COVID-19 into LTCFs 
(“Measures to prevent the entrance of COVID-19 into LTCFs 
by LTCF staff, visitors, and residents, depending on the level 
of SARS-CoV-2 transmission in the community nearby the 
LTCF [5] (Box 1)”), reducing the risk of COVID-19 spread 
within LTCFs (“Measures to prevent the risk of COVID-
19 spread by LTCF staff, visitors, and residents, depending 
on the level of SARS-CoV-2 transmission in the community 
nearby the LTCF [5] (Box 1)”), limiting the outbreak and 
optimizing residents’ care when a first resident, staff member, 
or visitor is infected (“Measures to implement when a new 
case of COVID-19 is confirmed in a LTCF resident, staff 
member, or visitor” and “Palliative care for COVID-19 nurs-
ing home residents”), educating and supporting staff mem-
bers (“Staff education to meet LTCF needs in response to 
the COVID-19 pandemic” and “Staff support to meet LTCF 
needs in response to the COVID-19 pandemic”).
The current interim EuGMS guidance that is aimed at 
LTCFs situated in areas with low to substantial community 
transmission (see Box 1) specifies also policies and waiv-
ers (“Policies and waivers to meet LTCF needs in response 
to the COVID-19 pandemic”) and LTCF organization and 
structure (“COVID-19 and LTCF organization and struc-
ture”) that may help LTCF to meet needs in response to the 
COVID-19 pandemic.
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The guidance presented here has been formulated by 
authors from different European countries who have experi-
ence with outbreaks of COVID-19 in LTCFs and who are 
board members of European national geriatric societies or 
of the EuGMS. The guidance included in this report is based 
on current knowledge at the time of manuscript transmis-
sion (August 25, 2020) (literature review through PubMed 
and international reports and statements) and will be regu-
larly modified according to newly published data and new 
experiences. The present guidance, that should not take prec-
edence over local, regional, or national recommendations, 
should be considered as an aid document for LTCFs to define, 
depending on local possibilities, the best protection strategy 
for residents and caregivers and possibly to help write local, 
Box 1  Adaptation of Infection Prevention and Control Measures to SARS-CoV-2 Transmission Level in the Community nearby the LTCF or in 
the LTCF
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regional, or national recommendations when they do not exist. 
Considering that certain proposed measures (testing, social 
isolation and quarantine) may have potential adverse effects, 
the document provides a list of measures that each require an 
assessment of the risk–benefit ratio on a case-by-case basis. 
This article also prepares LTCFs for future waves of the pan-
demic, as the number of COVID-19 cases rises sharply in 
many countries at the time of manuscript transmission.
Specific features of COVID‑19 transmission 
in LTCFs
SARS-CoV-2 is highly contagious, due to elevated viral 
loads in the upper respiratory tract. The long incubation 
period for COVID-19 (up to 14 days) [5] associated with the 
fact that asymptomatic residents, visitors, and staff members 
[3, 6, 7] and residents with atypical COVID-19 symptoms 
[8–10] contribute substantially to transmission complicates 
the early detection of cases.
• This suggests that infection prevention and control (IPC) 
measures aimed at keeping COVID-19 out of LTCFs and 
early detection of SARS-CoV-2 carriers, including those 
who are asymptomatic and with atypical symptoms, are 
essential for limiting transmission in LTCFs [11].
• Family, visiting health care professionals, and LTCF 
staff initially contributed to the transmission of 
SARS-CoV-2 within LTCFs, leading to a “lockdown” 
within the facilities. LTCF staff—including interim 
temporary or agency staff (hired from private organ-
isations to compensate for gaps in LTCF rotas due 
to COVID) who moved between LTCFs—were then 
vectors for virus transmission within the facility and 
spread among the community [2].
• This suggests that, as part of the reopening process, and 
for as long as the virus circulates outside the LTCFs, 
any SARS-CoV-2 introduction and transmission within 
LTCFs will be due to staff members, visitors, or residents 
who may have had contact with COVID-19 subjects out-
side the LTCF, especially during medical examination, 
hospitalisation or when residents go home or go to their 
family’s home for visits [11].
Properties of the SARS‑CoV‑2 reverse 
transcription polymerase chain reaction 
(RT‑PCR) testing when implemented 
in residents and staff members
The reverse transcription polymerase chain reaction (RT-
PCR) test, performed using nasopharyngeal swab (or other 
upper respiratory tract specimens, including throat swab 
or, more recently, saliva) is currently the most commonly 
used and reliable test for diagnosing COVID-19 [12]. The 
United States Centers for Disease Control and Prevention 
(US CDC) have published useful guidance for Collecting, 
Handling, and Testing Clinical Specimens for COVID-19 
[13]. Quick tests may have low sensitivity compared to the 
conventional real-time RT-PCR [14]. The RT-PCR test does, 
however, have some limitations [6, 12, 14], as displayed in 
Box 2.
Sensitivity of SARS‑CoV‑2 RT‑PCR
The sensitivity of the RT-PCR test seems acceptable in 
LTCF residents, probably higher than 90% (i.e. less than 
10% of residents who develop SARS-CoV-2 antibodies in 
the following days have a negative RT-PCR) [15]. Con-
versely, RT-PCR testing sensitivity may be lower in LTCF 
staff members than in residents (meaning that infected staff 
Box 2  RT-PCR test properties 
useful when interpreting testing 
results in LTCF residents, staff 
members, or visitors [5, 12, 14, 
15, 17, 18, 60]
- False negave results may occur in asymptomac or weakly symptomac subjects.  
- False negave results may be due to inappropriate ming of sample collecon (too early or 
too late). 
- False negave results mays be due to deficiency in sampling technique, especially for 
nasopharyngeal swabs. 
- An RT-PCR posive test for SARS CoV-2 reflects only the detecon of viral RNA and does not 
necessarily indicate the presence of a viable virus.  
- Duraon of culturable viral shedding longer than the 10 days previously described is possible 
in immunocompromised subjects, and possibly therefore in residents of LTCFs, and in paents 
with severe illness. 
- The cycle threshold (Ct) value of the quantave RT-PCR targeng E gene represents an 
indicator of the viral load (the Ct value is the number of replicaon cycles required to produce 
a fluorescent signal, with lower Ct values represenng higher viral RNA loads, considering that 
a Ct value of less than 40 is clinically reported as RT-PCR posive).  
- The successful isolaon of a virus in a cell culture and the Ct value of quantave RT-PCR 
targeng E gene seem correlated.  
- Paents with a Ct of above 33–34 (dependent however on the RT-PCR system) may not be 
contagious and therefore may be discharged from strict confinement. 
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members may more often test negative by RT-PCR than 
infected residents) [15]. This suggests that:
• Testing (when possible) residents, staff members, and 
visitors with COVID-19 symptoms may be an appropri-
ate strategy for the early diagnosis of the first COVID-19 
cases in LTCFs [11].
• When a new case of COVID-19 is confirmed in a LTCF 
resident, staff member, or visitor having entered the 
LTCF over the past 14 days, LTCF-wide testing (when 
possible) of all residents and staff members (even asymp-
tomatic) and repeating this testing strategy once a week 
in all previously negative subjects until the testing iden-
tifies no new COVID-19 cases for at least 14 days may 
be an appropriate strategy for diagnosing asymptomatic 
SARS-Cov-2 carriers and for preventing SARS-Cov-2 
dissemination [11].
• Because RT-PCR testing sensitivity is lower in staff 
members than in residents (partly because they are less 
immunocompromised and therefore less often sympto-
matic than residents when infected) [12], general IPC 
measures in staff members—including facemasks over 
the mouth and nose to contain respiratory secretions, 
hand hygiene and social distancing—is necessary to 
reduce the risk of transmission of SARS CoV-2 by staff 
members, even in the case of negative RT-PCR testing 
[14–16].
Duration of positive SARS‑CoV‑2 test results
The duration of the positive SARS-CoV-2 test result 
may be higher in immunocompromised than in 
non-immunocompromised subjects (positive RT-PCR testing 
lasts longer in residents than in staff members), and in subjects 
with severe disease [12]. Thus, around half of all nursing home 
residents still have positive test results 14 days after the initial 
positive results [15].
However, detection of viral RNA 10 days after positive test-
ing in non-immunocompromised asymptomatic subjects and 
20 days after positive testing in immunocompromised asymp-
tomatic subjects does not indicate the presence of a viable 
virus [5, 17]. After that period, most asymptomatic subjects 
who continue to have detectable SARS-CoV-2 RNA are no 
longer infectious [17, 18].
• This suggests the need to adapt the duration of isolation 
and the precautions implemented in subjects tested posi-
tive for COVID-19 to their health status (longer in immu-
nocompromised subjects, such as residents, than in non-
immunocompromised subjects, such as staff members) and 
to their symptoms (longer in the case of severe disease or 
of remaining symptoms) [11, 12, 19].
A few cases have also been reported positive after an ini-
tially negative RT-PCR test result. It is unclear as to whether 
this represents testing error, reinfection, or reactivation [12].
• This suggests that testing may be warranted in subjects who 
remain or become symptomatic after the above isolation 
period (10 or 20 days), and in whom an evaluation fails to 
identify a diagnosis other than SARS-CoV-2 infection [11, 
12, 19].
Box 3  Tasks of the Infection 
Prevention Control (IPC) focal 
point in LTCFs
- Coordinate COVID-19 IPC training for all employees, including consultant personnel (e.g. wound 
care, podiatry, barber) and volunteers.  
- Coordinate informaon sessions for residents and their family since they can be exposed to (or 
serve as a source of) pathogen transmission. 
- Provide audits on IPC pracces and feedback to employees. 
- Ensure adequate supplies of masks, alcohol-based hand rub, posters (targeng employees, 
residents and visitors to regularly use alcohol-based hand rub or wash hands), ssues and 
appropriate waste disposal. 
- Help to establish physical distancing in the facility, especially during meals and group acvies. 
- Apply specific guidance and measures, especially for residents in whom physical distancing can 
present parcular challenges (residents walking with purpose, for example)25,26
- Organize the condions of visitors’ entrance according to local and naonal guidelines. 
- Organize the use of video conferencing soware (on smartphones, tablets, portable computers), as 
well as plasc or glass barriers as much as possible to maintain human contact for residents and 
visitors23,24,49-51
- Organize the use of video consultaon technology  to bring together nursing home staff, 
physicians and hospital-based clinicians, family members and legal representaves and to thus 
maintain a high level of care during the COVID-19 pandemic period.21-24
- Avoid the sharing of health care workers among different wards within the same LTCF and between 
LTCFs to limit the risk of COVID-19 spread within and between LTCFs. 
- Organize and implement an adequate tesng strategy ( which can be intensified if necessary). 
- Organise the ending procedures of a necessarily imposed visitors’ lockdown, when the LTCF 
gradually opens its doors again. 
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Adverse effects of social isolation 
and quarantine in residents
Many older adults in LTCFs undergoing strict social iso-
lation have developed depression, anxiety, worsening 
dementia, sarcopenia, functional impairment, and failure to 
thrive.
• This suggests that social isolation has to be restricted 
to infected subjects and to those in close contact with 
Box 4  Recommended hygiene 
and distancing measures in the 
daily life of the health care per-
sonnel, visitors, and residents 
who go outside the LTCF, for as 
long as the virus is circulating 
outside the LTCF
- Wash hands frequently and carefully with water and soap for a minimum of 40 seconds or with an 
alcohol-based hand rub (containing at least 60% alcohol) for a minimum of 20 seconds. Especially 
aer touching any frequently used items or hard surfaces outside the home, including tables, door 
knobs, light switches, countertops, handles, desks, phones, keyboards, toilets, taps, and sinks. 
- Frequently disinfect used items and surfaces as much as possible. 
- When sneezing, cover the mouth and nose with a ssue or sneeze into the elbow to keep hands as 
clean as possible. Wash hands carefully aer sneezing or coughing. 
- Avoid touching the face when hands have not been cleaned with water and soap or with an 
alcohol-based hand rub. 
- Take social distancing seriously: stay at home as much as possible when not working. If a staff 
member needs to go out for necessies, keep a distance of at least 1 to 2 meters (Europe) or 6 feet 
(in the USA)   from other people. Do not share personal items such as phones. Disinfect areas aer 
bringing groceries or packages into the home, and wash fresh groceries.  
- Wear a cloth mask (or a surgical mask if available), especially in enclosed spaces and even in open 
spaces when social distancing may be difficult to maintain. Staff members should avoid touching the 
front of their mask  or should wash their hands if they do so. In all cases, naonal rules should be 
followed. 
Box 5  Measures that should be 
taken by staff members, visitors, 
and residents before they enter 
the facility, whether COVID-
19 positive or negative, for as 
long as the virus is circulating 
outside the LTCF, especially in 
areas with substantial commu-
nity transmission
- Staff members and visitors should wash their hands with a sanizer that contains at least 60% 
alcohol. The US CDCs have published the Guidance for Healthcare Providers about Hand Hygiene and 
COVID-1931
- Staff members and visitors should be given a surgical mask to be worn permanently during their 
stay in the facility. The mask should be changed once every 6 hours since the capability of cloth face 
covering to protect the staff members is unknown. The mask is not a substute for social distancing. 
- All staff members should change their clothes and shoes.  Clothes for daily life and work should be 
laundered according to the manufacturer's instrucons, using the warmest appropriate water 
seng, and dried completely. Shoes should be regularly disinfected. 
LTCF: Long-term care facility 
Table 1  Symptoms compatible with COVID-19 in the general population and in frail older people
Typical COVID-19 symptoms in the general population and in frail 
older people
Atypical COVID-19 symptoms possibly observed in frail older people
Temperature ≥ 37.5 °C Transient episodes of fever
Cough Oscillating temperature with transient episodes of hypothermia
Fatigue Malaise
Sputum Transient episodes of hypotension, with mottling
Shortness of breath Oxygen desaturation (< 95%), increased respiratory rate (> 25/min)
Muscle aches
Sore throat Anorexia, dry mouth, loss of weight
Headache Delirium, apathy, disorientation, lethargy, somnolence
Anosmia Balance impairment, dizziness, falls
Chills
Nasal congestion Conjunctivitis
Nausea or vomiting Diarrhoea
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infected subjects. When necessary, isolation has to be 
associated as much as possible with measures to prevent 
negative effects on residents’ mental and health status 
[20–24].
Second interim EuGMS guidance to prepare 
European long‑term care facilities 
for COVID‑19
The EuGMS guidance supports the IPC World Health 
Organization guidance [25] and recommends that an infec-
tion prevention and control focal point (IPCFP) should be 
set up in every LTCF for supervising measures (1) to prevent 
the entrance of COVID-19 and COVID-19 spread, especially 
when a new case of COVID-19 is confirmed, (2) to opti-
mize care for infected residents, including palliative care if 
needed, (3) to educate and support staff members, consider-
ing that policies should be adapted to give LTCF providers 
and professionals flexibility to meet the demands of resi-
dents’ care needs in response to the COVID-19 pandemic. 
To be easily readable tables and boxes have been prepared to 
be complementary to the text and measures were not detailed 
when a reference is available.
Measures to prevent the entrance of COVID‑19 
into LTCFs by LTCF staff, visitors, and residents, 
depending on the level of SARS‑CoV‑2 transmission 
in the community nearby the LTCF [11] (Box 1)
Box 3 displays IPCFP missions to prevent the entrance 
of COVID-19 into the LTCF, in accordance with the IPC 
World Health Organization guidance [25]. The main mis-
sions include the following tasks:
– Limitation of the number of visitors, with due considera-
tion that the isolation of residents may have a negative 
effect on their mental and somatic health status (allow-
ance should be made for this). Indeed, the need to pro-
tect residents from the spread of COVID-19 should be 
balanced with the critical need of support provided by 
families and other persons [20, 26–29]. LTCF lockdown 
should therefore be restricted to LTCFs with COVID-19 
positive cases or, temporarily, when SARS-CoV-2 circu-
lates strongly outside the LTCF, according to national or 
local rules.
– General measures in accordance with national rules for 
residents, staff members, and visitors, especially those 
relating to hygiene and social distancing, for all activities 
conducted outside the LTCF (Boxes 4, 5) [19, 30–32].
– Screening for COVID-19 symptoms (the screener 
should be wearing a surgical mask) before allowing 
staff members, visitors, or residents to enter the facil-
ity (Table 1) [11, 25]. Any contact with suspected or 
confirmed COVID-19 cases also needs to be checked. 
Subjects with COVID-19 symptoms or those in contact 
with suspected or confirmed COVID-19 cases should 
not be allowed to enter the LTCF unless their RT-PCR 
test is negative [11].
– Systematic testing before admission of new residents. 
Only RT-PCR-negative residents can be admitted if the 
LTCF is free of COVID-19 cases [11].
– Consider testing the residents who have spent a period 
of time outside the LTCF (at hospital for example), espe-
cially when the virus is circulating substantially in the 
visited area [11].
– Consider regular testing (for example weekly in areas 
with substantial community transmission) of staff mem-
bers, visitors, and residents who are at a high risk of 
Box 6  Measures that should be 
taken by staff members, visi-
tors, and residents during their 
stay in the LTCF for as long as 
the virus is circulating outside 
the LTCF, especially in areas 
with substantial community 
transmission
- Residents, staff and visitors should constantly maintain social distancing (keep a distance from 
other people of at least one to two metres in many European countries, 6 feet in the US, 
considering that the greate r the distance between people, the more human-to-human 
transmission is avoided),  especially when mask wearing is difficult (e.g. during breaks and meals).  
- Staff and visitors should not share personal items such as phones. They should wash their hands 
frequently (with soap and water for a minimum of 40 seconds or with alcohol-based hand rub for a 
minimum of 20 seconds),  especially when  hands   are   dirty,  before  and  aer  touching  residents 
(although this should be avoided  as  much  as  possible), aer using the toilet, before and aer 
preparing food, before eang, and  aer  coughing  or sneezing. 
- Staff should help residents with frequent hand hygiene, in parcular when hands are dirty, before   
and aer touching other people (although this should be avoided as much as possible), aer using 
the toilet, before eang, and aer coughing or sneezing. 
- Staff should disinfect items and surfaces used or touched for the care of residents (e.g. 
stethoscope). They should avoid touching their face or the resident’s face and wash their hands if 
they touch the front of their mask. 
LTCF: Long-term care facility 
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encountering COVID-19 outside the LTCF (health care 
workers who have an extra care activity outside the 
LTCF, visitors of several LTCFs, residents receiving 
dialysis or going to hospital ambulatory services, etc.) 
[11].
– Checking that residents, LTCF staff, and visitors pre-
viously tested positive for COVID-19 meet the LTCF 
entrance criteria according to national guidance. For 
example, in the US, the UK, and France, return-to-work 
criteria for staff members with mild to moderate illness 
who are not severely immunocompromised are: (1) at 
least 10 days have passed since symptoms first appeared 
and (2) at least 24 h have passed since last fever without 
the use of fever-reducing medications and (3) symptoms 
(e.g., cough, shortness of breath) have improved. In sub-
jects who were asymptomatic throughout their infection: 
at least 10 days have passed since the date of their first 
positive viral diagnostic test. In immunocompromised 
subjects or in subjects with severe illness (most of the 
residents are immunocompromised, and possibly some 
staff members and visitors), isolation should last for at 
least 14 to 20 days and for as long as the subject has 
symptoms compatible with COVID-19 infection. In 
subjects who become symptomatic during the 90 days 
following positive testing and whose evaluation fails to 
identify a diagnosis other than SARS-CoV-2 infection 
(e.g., influenza), evaluation for SARS-CoV-2 reinfection 
is warranted [11].
– Limit short-stay admissions to LTCFs (respite care, reha-
bilitation, transitional care, as well as intermediate-care, 
step-down, transitional care, convalescence), unless these 
residents—who represent a higher infection risk to resi-
dents—are in a building or unit with separate entrance, 
staff and services [26].
Measures to prevent the risk of COVID‑19 spread 
by LTCF staff, visitors, and residents, depending 
on the level of SARS‑CoV‑2 transmission 
in the community nearby the LTCF [11] (Box 1)
The infection prevention and control focal point (IPCFP) 
should also organize the following tasks:
– Healthcare professionals and family members visiting 
the LTCF and allowed to enter the facilities should sign 
a form agreeing to adhere to standard and transmission-
based precautions to prevent a COVID-19 spread within 
the LTCF (Boxes 5, 6). They should also sign a registry 
with contact details to facilitate testing and contact trac-
ing should a new case be diagnosed in the LTCF. Face 
masks, hand hygiene and social distancing are consensual 
measures when entering a European LTCF, and masks 
should be available at the LTCF front entrance. Some 
countries, such as the UK, apply stricter measures, with 
staff members wearing gloves and aprons for any form 
of resident care, and all visitors required to don the same 
Personal Protective Equipment as a condition of entry.
– The US CDC has published specific guidance for stand-
ard and transmission-based precautions to prevent 
COVID-19 spread in the memory care units of LTCFs 
[33].
– Every new resident should be admitted to a single occu-
pant room and isolated for 14 days, in the same way as 
residents leaving the LTCF (for a medical examination 
or to visit families for example). If COVID-19 symptoms 
occur (Table 1), the resident should be tested. Due to 
the fact that COVID-19 residents can be asymptomatic, 
those leaving the LTCF (especially for medical consulta-
tion) should be ideally tested 5 to 7 days after their LTCF 
return in areas with substantial community transmission.
– Daily screening for COVID-19 symptoms (including 
atypical symptoms) (Box 2) should be incorporated into 
the routine daily observation with clear COVID alert-
ing features. Testing should take place if there is any 
suspicion of infection. LTCFs should be provided with a 
sufficient supply of test kits for PCR testing to meet diag-
nostic needs, with access to a laboratory that can provide 
results of PCR testing within 24 h if possible [34].
– Administrative records should be updated daily on the 
basis of COVID-19 symptoms, to record whether a resi-
dent has received a COVID-19 test, has been isolated due 
to COVID-compatible symptoms, and/or has required 
any other non-standard IPC measures.
The IPCFP should also:
– Provide information to the residents and their family/
health care providers and organize advance care plan-
ning to support them in understanding and sharing their 
personal values, life goals, and preferences regarding 
medical care, including appropriate advance directives 
(ADs) and decisions about escalation to hospital in the 
event of any future COVID-19 outbreak in the LTCF. An 
explanation of the limited success of mechanical ventila-
tion in older adults with COVID-19 should be given as 
well as a description of care that can be provided in the 
LTCF in the event of non-hospitalization [35]. Advance 
care planning has to be timely and proactively executed 
to provide high-quality long-term care, contributing to 
the quality of life in the remaining life span of the resi-
dents [35].
– Prepare a file with all data necessary for the laboratory to 
organize testing and test result reporting (name, address, 
date of birth, insurance data, etc. of all residents, staff 
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members, and visitors) in the event of a COVID-19 out-
break in the LTCF. There should also be a list of those 
responsible for performing specimen collection, includ-
ing the facility’s trained staff members. These people 
need to be trained to collect specimens correctly, using 
the appropriate personal protective equipment (PPE) 
[36].
In a cohort study of French LTCFs, mortality rates related 
to COVID-19 were lower among nursing homes that imple-
mented staff confinement with residents compared with 
those in a national survey, suggesting that self-confinement 
of staff members with residents in areas with substantial 
community transmission may help protect LTCF residents 
from mortality related to COVID-19 and residents and staff 
from COVID-19 infection [37].
Measures to implement when a new case 
of COVID‑19 is confirmed in a LTCF resident, staff 
member, or visitor
In some countries, COVID-19 geriatric support platforms 
have been set up in local hospitals, often in conjunction with 
public health, with a hotline for LTCFs [38]. These sup-
port platforms have been shown to be helpful for LTCFs in 
organizing IPC measures, especially repeated facility-wide 
RT-PCR testing and reporting of test results. The hotline can 
be useful for responding to the information requirements of 
the LTCF staff regarding care procedures, in connection with 
other specialized units, (emergency, intensive care, palliative 
care, pulmonary medicine, infectious diseases and hygiene 
units), possibly by telemedicine [39].
Measures that need to be taken as quickly as possible 
when a new case of COVID-19 is confirmed in a resident, 
staff member, or visitor include the following:
Within the first 12 h:
– Staff should be made aware of the existence of the 
advance care planning, including advance preferences 
or directives for all residents who provide consent [35].
– Residents should be restricted to their room and visits 
reduced to essential health care professionals only (situ-
ation to be adapted for end-of-life residents and for those 
suffering psychological distress, and associated with 
measures to limit the negative effects of social isola-
tion on residents’ mental/health status and well-being) 
[19, 20, 26] (Box 3). Any staff members or visitors who 
test positive for COVID-19 should not enter the LTCF 
until they meet the return criteria, in accordance with 
national guidance (see “Measures to prevent the entrance 
of COVID-19 into LTCFs by LTCF staff, visitors, and 
residents, depending on the level of SARS-CoV-2 trans-
mission in the community nearby the LTCF [5] (Box 1)”) 
[17].
– If it is not possible to exclude staff members for organi-
zational reasons, the US CDC has published Strategies to 
Mitigate Healthcare Personnel Staffing Shortages [40].
– If a resident tests positive for COVID-19, admission to a 
COVID-19 setting specialized in geriatric care (in hospi-
tal, in a specific nursing home location if such facilities 
are available with, if appropriate, agreement of family/
caregiver/legal representative) should be considered or 
set up via the application of zoning in the nursing home 
itself. This will separate the infected resident from the 
others, and optimize care for the COVID-19 residents 
[11, 15, 34, 41]. Excluding all new positive residents dur-
ing each facility-wide testing may reduce the LTCF staff 
workload, optimize IPCs and reduce the LTCF “viral 
load”, therefore reducing COVID-19 spread in the LTCF. 
If the LTCF can provide appropriate isolation and staff-
ing, an area of the facility should be dedicated for the 
care of residents with suspected or confirmed COVID-
19. There should be a specific staff and a clear delinea-
tion of risk zones [41]. Organized staff into teams who 
work exclusively within COVID-19 and non-COVID-19 
zones is strongly recommended [38, 42]. Because work-
Box 7  Precautions for LTCF 
staff who enter the room of a 
patient with known or suspected 
COVID-19 [25, 30, 32, 44]
- Standard precauons 
- Use contact and droplet precauons and PPE including  
- Filtering face piece respirator (N95 respirator or equivalent protecon mask)5 
- Gown 
- Gloves 
- Eye protecon (protecve eyewear with gaps between glasses and the face are not likely to 
protect eyes from all splashes and sprays) 
- PPE should be put on and removed carefully following the recommended procedures to 
avoid contaminaon.  
- Employees should remove PPE just before leaving the resident’s room, and discard it in the 
medical waste bin.  Hand hygiene should always be performed before pung on and aer removing 
PPE.  
LTCF: Long-term care facility; PPE: personal protecve equipment 
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ing exclusively with COVID-19 residents is physically 
and emotionally exhausting, thought should be given as 
to how to rotate staff teams, allowing appropriate periods 
of leave (at least 7 days), between working in COVID-19 
units and returning to the mainstream. Distinction should 
also be made between residents able to understand/tol-
erate their isolation (e.g. cognitively intact residents) 
and those more likely to suffer from isolation (e.g. resi-
dents with dementia and depressed mood or who walk 
with purpose) who may be better cared for in cohorted 
or zoned areas. LTCF COVID-19 units should receive 
transfers from within the facility as well as new admis-
sions/re-admissions from COVID-19-positive hospitals. 
In Lombardy (Italy) however, public policies aimed at 
discharging COVID-19 cases from hospitals to LTCFs 
to improve the capacity of the health systems to face the 
lack of hospital beds are suspected to have also increased 
the risk of infection in the nursing homes’ hosts [43, 44].
Therefore, if possible, such a COVID-19 LTCF unit 
should have a separate entrance/exit or try to install tempo-
rary walls or doorways at the entrance. If it is not possible 
to segregate COVID-19-positive patients in a separate unit, 
such patients should be cohorted in one area of the affected 
unit and dedicated staff should be assigned to care for them. 
This is particularly important for residents with dementia 
[45].
– The establishment of COVID-positive “red” areas also 
enables residents, with and without dementia, to mobilise 
safely outside their rooms, minimising the risk of decon-
ditioning associated with prolonged isolation in a private 
room [41, 42].
Any staff member entering the room of a resident with 
known or suspected COVID-19 (including those with 
atypical symptoms) should adhere to standard precautions 
[45], apply contact and droplet precautions and use per-
sonal protective equipment (PPE) (Box 7).
Within the first 24–48 h: 
– Facility-wide testing of all LTCF residents, staff mem-
bers, and visitors having entered the LTCF over the past 
14 days, including those without symptoms. This can be 
challenging for some of the residents, especially with 
cognitive impairment, for staff members, and for visi-
tors who may refuse testing. All subjects who cannot be 
tested have to be managed in the same way as COVID-19 
positive subjects  [45].
– Repeat this testing strategy once a week in all previ-
ously negative subjects until the testing identifies no 
new COVID-19 cases for at least 14 days since the most 
recent positive result. The US CDC has published guid-
ance for preparing LTCFs to perform facility-wide testing 
[46]. The LTCFs should be prioritized for rapid, point 
Table 2  Management of COVID-19 end-of-life symptoms on-site adapted from ([34])
Symptom Consider Tailored on comorbidities and symptom burden




As needed (PRN) or regular doses
Start at 2.5 mg or 5 mg PO/SubL
q4–6 h: avoid repeated morphine doses if 
CrCl < 30
20 mg/mL, consider start at 2.5 mg or 5 mg PO 
(per os)/SubL (sublingual) q4–6 h
Higher doses of morphine or oxycodone for higher symptom burden and non-opioid naïve patients
Dyspnea Oxygen by nasal cannula if capillary pulse oxygen is < 90%










Start 0.5 mg PO/SubL q6–12 h
Restlessness Parenteral benzodiazepine See above
Excess secretions Risk of delirium with atropine; limit intravenous fluids
Atropine eye drops used sublingually
Glyclopyrrolate if PO possible
Scopolamine patch (anticholinergic side effects)
1 drop q2h
1‒2 mg bid-tid PRN
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of care testing as this is the best way to manage the epi-
demic in real time [34].
– Report positive SARS-CoV-2 results to local authorities 
and maintain records of staff members and residents who 
have positive tests to facilitate the reporting of aggregate 
data to national databases [11].
– Assess IPC practices with help from the proximity 
COVID-19 support platform for LTCFs or a hygiene plat-
form in the proximity hospital while conducting facility-
wide testing [47].
– Isolation and COVID-19 precautions in residents tested 
positive for COVID-19 should last until they meet the 
end of isolation criteria, in accordance with national 
guidance. As indicated previously, isolation and COVID-
19 related precautions in residents/staff members previ-
ously tested positive for COVID-19 should probably end 
safely [17]:
• In non-immunocompromised persons: 10  days after 
symptom onset (or 10 days after the positive testing in 
subjects who are not symptomatic) and when subjects are 
asymptomatic for at least 24 h.
• In immunocompromised persons (the case for most of the 
LTCF residents) or those with a severe illness: 20 days 
after symptom onset or after positive testing and when 
subjects are asymptomatic for at least 24 h. Some experts 
recommend to end isolation 14 days after positive testing 
and when subjects have been asymptomatic for at least 
24 h [34].
• If control testing is implemented in patients with a Ct of 
above 33 (see definition in Box 2) [18]:
– Entries are only possible at least 14 days after the 
end of the isolation of the last resident tested positive 
when no new residents and staff members have any 
signs of COVID-19 [11].
– Because immobility may lead to sarcopenia and 
functional impairment [29], measures should also 
be implemented to limit the physical effects of quar-
antine in residents [48], associated with measures to 
limit the risk of deep vein thrombosis, COVID-19 
being associated with a procoagulant state [34, 49]. 
One example of physical activity programme that 
can be proposed in residents who are isolated in their 
room is the MATCH (Maintenance of Autonomy 
Through exercise Care during Hospitalization) pro-
gramme that comprise specific and adapted exercises 
(e.g., seated knee extension, sit to stand, step aside, 
chair for-ward bend, bipedal and unipedal static bal-
ance, and wall squat) and walking time. This pro-
gramme, available for notebook with optional and 
additional training video, has been tested and imple-
mented during this COVID-19 pandemic in geriatric 
hospital units and long-term care with no individual 
Internet access [48].
Palliative care for COVID‑19 nursing home residents
As indicated previously, advance care planning has to be 
timely and proactively discussed with the resident and/or 
their family, including “do not resuscitate”, “do not intu-
bate”, and “do not hospitalize” [35]. Physicians, nurse 
practitioners, physician assistants, and social workers can 
contribute to the discussion. Conversations should include 
an explanation of the limited success of mechanical ventila-
tion in older adults with COVID-19, and a description of the 
type of care which can be provided if non-hospitalization is 
decided. Conversations should emphasise the fact that symp-
toms of a resident with COVID-19 can worsen rapidly [34].
Proposals for the management of COVID-19 end-of-life 
symptoms consistent with realistic goals of care, and tai-
lored with respect to comorbidities and symptom burden, are 
displayed in Table 2. The discontinuation of non-essential 
medications should be considered (including intravenous 
fluids that can induce dyspnoea and increase secretions and 
prophylactic anticoagulation, weighing this against the fact 
that COVID-19 is procoagulant) to improve resident comfort 
and reduce nursing administration time. Checking labs or 
examinations that can expose residents and staff should be 
avoided [49].
COVID-19 makes it difficult to hold face-to-face end-
of-life discussions and increases the chances of the resident 
dying without someone present [50]. To avoid situations 
in which the infected residents die without the possibility 
to say goodbye to their relatives, LTCFs should organize a 
separate room in which the infected resident may be placed 
and should take special precautions to allow families to 
be present when the loved one passes. In some cases, the 
resident will have no relatives and an LTCF staff member 
becomes his/her very close everyday caregiver. In this case, 
the death of the resident may have a detrimental impact on 
the mental health of the care assistants/nurses, justifying the 
need to develop programmes allowing reflection and relief 
of emotions to reduce the burden for both the relatives and 
the nursing home staff [51].
Staff education to meet LTCF needs in response 
to the COVID‑19 pandemic
The COVID pandemic highlights the need for universal 
adoption of standards of medical care for physicians and 
other staff members in nursing homes in Europe [52]. 
Indeed, in this COVID-19 pandemic period, the assessment 
of patients prior to admission by a specialist in geriatric 
medicine or old-age psychiatry (or both if necessary) is 
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more useful than ever, to (1) detect and remediate illness 
and functional loss, and (2) better delineate care needs for 
the older person, so as to clarify whether NH admission 
can be avoided or deferred. The multiple missions of IPCFP 
necessitate a medical leadership (the US medical director 
can serve as a model) to coordinate the implementation of 
the above measures. These measure should be set up in col-
laboration with (1) nurses who have gerontological training, 
especially in dementia and palliative care, (2) care attendants 
who have due training in the care of older people, (3) physi-
cians with a formal competencies in geriatric medicine and 
old-age psychiatry, and (4) specialist gerontology services, 
including geriatricians, old-age psychiatry and clinical nurse 
specialists as well as (5) specialists in palliative care sup-
port. COVID-19 geriatric support platforms can serve to 
liaise with IPCFP, hospital geriatric units (public or private), 
clinical nurse specialists, specialists in palliative care and 
infectious diseases, IPCFP of other LTCFs in the region, and 
public health [47]. In a recent study, every 20 min (per resi-
dent day) increase in registered nurse staffing was associated 
with a 22% reduction in the number of confirmed COVID-19 
cases (in facilities with at least one confirmed case) and with 
26% fewer COVID-19 deaths (in facilities with at least one 
death due to this infection). This confirms the importance of 
the qualified staff in preventing SARS-CoV-2 dissemination 
in LTCFs [53].
Staff support to meet LTCF needs in response 
to the COVID‑19 pandemic
The chronic understaffing in LTCFs—due to part-time 
employment, punitive measures related to sick leave, low 
wages, obligation to work when unwell—explains why it 
may be difficult in most LTCFs to (1) monitor residents for 
COVID-19, (2) follow protocols to keep residents physi-
cally distant and (3) implement public health measures to 
reduce the transmission of the virus. This is particularly the 
case when isolating COVID-19 residents with dementia who 
may not understand or follow the procedure exacerbates their 
behaviour [54].
The workload of LTCF staff members is has been 
increased by the pandemic because of: the ban of family 
members and other volunteers who provide supportive care; 
and the increase of staff absenteeism due to COVID-19 
symptom and/or fear of contracting the virus or transmit-
ting it to their loved ones. In addition, due to the COVID-19 
pandemic, the actions of health authorities have generated 
a feeling of abandonment in LTCF staff members and of 
degrading [55]. Coupled with the moral distress of losing 
residents they have cared for over many years, the potential 
guilt of their own role in transmission, and the feeling of 
violating their own ethical or moral codes when working 
under high pressure, there is a high risk of staff experiencing 
psychological trauma in LTCFs. Because LTCF staff mem-
bers need more support and recognition than ever, consid-
erations for nursing home leaders and regulators to support 
the health and well-being of nursing home staff and resi-
dents have been proposed. These include (1) measures to 
keep staff informed (because expert advice evolves) and (2) 
health measures (focussing on stress management and meet-
ing the basic needs of staff) [54], by (a) optimizing human 
resources (redeploying and educating staff from other health 
care facilities (such as hospitals) to work in nursing homes), 
(b) implementing new clinical practices related to COVID-
19, especially end-of-life care including advanced care plan-
ning, symptom relief, and post mortem care, (c) providing 
education and training, and (d) acquiring PPE [56]. In Hong 
Kong, for example, all health care institutions keep PPE in 
stock (exchanged every 3 months) [56].
Policies and waivers to meet LTCF needs 
in response to the COVID‑19 pandemic
Policies and waivers implemented by the American Cent-
ers for Medicare and Medicaid Services (CMS) to give 
long-term care providers and professionals flexibility to 
meet the demands of resident and patient care needs in 
response to the COVID-19 pandemic can be very useful 
for the European countries [57]. These policies and waiv-
ers include the possibility for hospitals to deliver care in 
temporary expansion sites to accommodate COVID-19 
patients, including COVID-19 residents. LTCFs can be 
repurposed as expansion sites and designated as COVID-
19 patient care facilities to achieve population separation 
and transmission mitigation.
CMS have also enabled the opening or use of non-LTCF 
buildings for unmet COVID-19 isolation and treatment as 
well as the temporary use of rooms in the facilities (activ-
ity rooms, meeting/conference rooms, or dining rooms) for 
resident care, to expand surge capacity and for purposes of 
cohorting and infection control.
As described in Box 3, telehealth provides new opportu-
nities to enhance healthcare quality in LTCFs that include 
specialty consultations by physicians and non-physician 
practitioners where appropriate [22].
CMS also allow for physician delegation of tasks or 
required visits to a physician assistant, nurse practitioner, 
or clinical nurse specialist. CMS recommend that a LTCF 
may not employ a nurse assistant for longer than four 
months unless he/she meets certain training/certification 
requirements. The CMS allow for the redeployment of 
employed physicians, utilization of available trainee staff, 
and recruitment of community and retired physicians in 
LTCFs.
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It must however be strongly reminded that all new 
HCPs must adhere to standard and transmission-based pre-
cautions to prevent a COVID-19 spread within the LTCF 
(Box 6).
To enable clinicians to better focus on the care needs of 
residents, CMS have temporarily given LTCF providers 
relief from paperwork, reporting and audit requirements 
[57].
COVID‑19 and LTCF organization 
and structure
The probability of having a COVID-19 case in LTCFs, such 
as other infections (influenza, Norovirus, Clostridium dif-
ficile), is higher for larger facilities in urban locations [58]. 
The COVID-19 pandemic offers the opportunity to rethink 
the design of LTCFs so as to provide a high quality of regu-
lating ventilation and temperature, divide them into smaller 
wards by clustering smaller numbers of residents in living 
and/or dining rooms, or even in small-scale freestanding 
living facilities (such as the Green House Model or Green 
Care Farms), with more space per resident, separate offices 
spaces and additional separate rooms for residents who need 
isolation due to infection, and to provide the possibility for 
family members to stay with the resident at the time of his/
her death [52, 59].
Conclusion
This second EuGMS Interim guidance to prepare European 
Long-term care facilities for COVID-19 takes into account 
studies, guidance, documents, and experience available up 
to August 25, 2020.
Any changes to the current guidance will be published 
according to new knowledge on this topic, especially once 
data are available on the follow-up of symptoms, interven-
tions, course of the disease in COVID-19-positive residents, 
vaccination schedules, point of care testing, interactions 
between COVID-19 and flu, and on serology in residents, 
visitors, and staff members.
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